- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement.
- [No authors listed]
- Am Fam Physician. 2020 Feb 15;101(4):233-238.
- PMID: 32053325
- PubMed abstract
- Guidelines
- Free Full Text
CME Activity:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer.
- PMID: 32053324
- PubMed abstract
- Source abstract
- Mismatch repair gene pathogenic germline variants in a population-based cohort of breast cancer.
- Nguyen-Dumont T, Steen JA, Winship I, Park DJ, Pope BJ, Hammet F, Mahmoodi M,nTsimiklis H, Theys D, Clendenning M, Giles GG, Hopper JL, Southey MC.
- Fam Cancer. 2020 Feb 14. doi: 10.1007/s10689-020-00164-7. [Epub ahead of print]
- Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitors.
- Garufi G, Palazzo A, Paris I, Orlandi A, Cassano A, Tortora G, Scambia G, Bria E, Carbognin L.
- Expert Opin Pharmacother. 2020 Feb 13:1-13. doi: 10.1080/14656566.2020.1724957. [Epub ahead of print]
- PMID: 32052646
- PubMed abstract
- Source abstract
- Review